Artificial intelligence has moved from conference-hallway buzzword to something turning up in real clinical workflows, and AI in pain medicine is no longer a hypothetical. On this week's PainExam Podcast, Dr. David Rosenblum works through what the technology is actually doing in our field right now, using "Artificial Intelligence and Pain Medicine: An Introduction" (Hagedorn et al., Journal of Pain Research, 2024) as the framework. If you have been wondering whether AI in pain medicine deserves your attention or is simply the next round of vendor noise, this is a useful place to start.
Here is the short version for busy clinicians.
Why AI in pain medicine is not just another health tech cycle
Every few years something gets billed as the technology that will transform medicine, and most of it turns out to be a new interface layered on an old problem. The argument for artificial intelligence being a genuine inflection point is that it changes what can be computed, not merely how data is displayed. Pattern recognition across large, messy, multimodal datasets is exactly the kind of problem our specialty generates constantly, and exactly the kind of problem clinicians have no practical way to solve by hand.
Consider what a single chronic pain patient produces: years of imaging, a medication history with partial responses and side effects, procedure notes, functional scores, psychosocial screening, and free-text documentation from multiple specialties. No physician can hold all of that in working memory and extract the pattern. A model can. That difference in kind, not degree, is why AI in pain medicine is being taken seriously by people who were skeptical of the last several technology waves.
Where AI in pain medicine is showing up today
Machine learning in clinical trial design
Pain research has a long-standing patient selection problem. Heterogeneous populations, high placebo response, and outcome measures that do not always track function have made trials expensive and frequently underpowered for the question that matters. Machine learning is being used to sharpen inclusion criteria and identify which patients are likely to show a measurable signal. That improves trial efficiency and, over time, the quality of the evidence we are all practicing from.
This matters more than it sounds. A great deal of what we argue about at conferences comes down to trials that were never designed to detect the effect in the subgroup we care about. Better patient selection upstream means fewer equivocal results downstream.
Natural language processing in the workflow
This is the piece most physicians will feel first. Natural language processing tools handle documentation, chart summarization, and note generation, which returns attention to the patient in front of you rather than the screen beside you. There is also an emerging role in doctor-patient communication: translating clinical language into something a patient can actually act on, and surfacing the questions a patient did not know to ask.
For a busy interventional practice, the realistic near-term value of AI in pain medicine is measured in minutes returned per encounter. That is not glamorous, but it is real.
Deep learning and outcome prediction
The clinically interesting question is not "does this treatment work" but "does it work for this patient." Deep learning approaches to outcome data aim at exactly that: identifying who is likely to respond to a given intervention before you perform it. For interventional pain, where procedures carry cost, risk, and real recovery time, better pre-procedure prediction may be the highest-value application on the entire list.
Disease recognition and treatment selection
Narrowing a differential faster, flagging patterns that are easy to miss on a crowded clinic day, and supporting the choice between two reasonable options are all near-term applications. Downstream, the same capability feeds cost savings, time savings, and faster product development cycles across the industry.
What AI in pain medicine looks like day to day
None of this replaces the clinical encounter. Imaging still needs to be correlated with the physical exam. The history still tells you things no model will extract from a chart, including the things a patient only mentions on the way out the door. The realistic picture is augmentation: a second set of eyes that never gets tired, attached to a physician who knows when to overrule it.
Where the evidence for AI in pain medicine is still early
Worth being clear-eyed here. Much of the published work is proof-of-concept rather than validated at the bedside. Model performance in a curated dataset is not the same as performance in your clinic, with your population, your referral patterns, and your documentation habits. Questions about data quality, generalizability, algorithmic bias, and regulatory oversight remain genuinely unresolved.
Bias deserves specific mention. A model trained on a population that does not resemble yours will fail in ways that are difficult to detect, because it will fail confidently and in a format that looks authoritative.
How to evaluate an AI tool before you adopt it
- What was it trained on? Population, size, and source matter more than the headline accuracy figure.
- How does it fail? A vendor who cannot describe failure modes has not studied them.
- Was it validated externally? Internal validation on the training population tells you very little.
- Where does it sit in the workflow? A tool that adds clicks will not survive contact with a full clinic schedule.
- Who is accountable for the output? In practice, you are. Adopt accordingly.
The bottom line on AI in pain medicine
Artificial intelligence will not replace clinical judgment. It is already starting to augment it, from trial design through to the exam room. The physicians who understand where the technology is headed, including its limits, will be the ones positioned to use it well and to push back intelligently when a tool overreaches. Understanding AI in pain medicine is quickly becoming part of staying current in the specialty, much as understanding ultrasound guidance became unavoidable a decade ago.
Frequently asked questions
Will AI in pain medicine replace pain physicians? No. Current evidence supports augmentation of clinical decision-making, not replacement. Procedural skill, physical examination, and the therapeutic relationship remain human work.
Is any of this ready for routine clinical use? Documentation and workflow tools are the most mature. Predictive and diagnostic applications are promising but largely still in validation.
What should I read first? Start with the Hagedorn introduction cited below, then listen to the episode for the clinical framing.
Listen to the episode
AI in Pain Medicine: What Every Physician Needs to Know is available now on the PainExam Podcast, Apple Podcasts, and Spotify.
Reference: Hagedorn JM, George TK, Aiyer R, Schmidt K, Halamka J, D'Souza RS. Artificial Intelligence and Pain Medicine: An Introduction. J Pain Res. 2024;17:509-518.
Living with chronic pain?
Dr. David Rosenblum sees patients in Brooklyn, NY for interventional and regenerative pain treatment, including epidurals, nerve blocks, spinal cord and peripheral nerve stimulation, and PRP/BMAC. Virtual second-opinion consultations are available for patients outside the New York area.
Dual board-certified in Anesthesiology and Pain Medicine · New York Magazine Top Doctor 2016–2026
Continue your education with NRAP Academy
NRAP Academy offers CME in neuromodulation, regional anesthesia, and pain medicine.
CME Course CalendarVirtual Pain FellowshipPainExam Board Prep
Visit NRAPpain.org to learn more.